APA (7th ed.) Citation

Goyal, S., Goswami, A., Khurana, P., Singh, K., Ghoshal, I., & Kulkarni, A. (2023). 864 AVA-NP-695, a potent and selective ENPP1 inhibitor, demonstrates strong anti-tumor efficacy as monotherapy and in combination with radiation. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Goyal, Sandeep, Avijit Goswami, Princy Khurana, Kawaljit Singh, Ishani Ghoshal, and Aditya Kulkarni. 864 AVA-NP-695, a Potent and Selective ENPP1 Inhibitor, Demonstrates Strong Anti-tumor Efficacy as Monotherapy and in Combination with Radiation. BMJ Publishing Group, 2023.

MLA (9th ed.) Citation

Goyal, Sandeep, et al. 864 AVA-NP-695, a Potent and Selective ENPP1 Inhibitor, Demonstrates Strong Anti-tumor Efficacy as Monotherapy and in Combination with Radiation. BMJ Publishing Group, 2023.